{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T19:38:26Z","timestamp":1743104306397,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":94,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789819901128"},{"type":"electronic","value":"9789819901135"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-0113-5_10","type":"book-chapter","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:23:23Z","timestamp":1678879403000},"page":"191-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pseudotyped Viruses for Lyssavirus"],"prefix":"10.1007","author":[{"given":"Wenbo","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caifeng","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1128\/JVI.01153-10","volume":"84","author":"DL Horton","year":"2010","unstructured":"Horton, D.L., et al.: Quantifying antigenic relationships among the lyssaviruses. J. Virol. 84, 11841\u201311848 (2010)","journal-title":"J. Virol."},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3201\/eid1412.080750","volume":"14","author":"IV Kuzmin","year":"2008","unstructured":"Kuzmin, I.V., et al.: Possible emergence of West Caucasian bat virus in Africa. Emerg. Infect. Dis. 14, 1887\u20131889 (2008)","journal-title":"Emerg. Infect. Dis."},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1586\/14760584.3.4.333","volume":"3","author":"A Fooks","year":"2004","unstructured":"Fooks, A.: The challenge of new and emerging lyssaviruses. Expert Rev. Vaccines. 3, 333\u2013336 (2004)","journal-title":"Expert Rev. Vaccines"},{"key":"10_CR4","first-page":"185","volume":"125","author":"SM Brookes","year":"2006","unstructured":"Brookes, S.M., Healy, D.M., Fooks, A.R.: Ability of rabies vaccine strains to elicit cross-neutralising antibodies. Dev. Biol. 125, 185\u2013193 (2006)","journal-title":"Dev. Biol."},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1099\/vir.0.065953-0","volume":"95","author":"T Nolden","year":"2014","unstructured":"Nolden, T., et al.: Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus. J. Gen. Virol. 95, 1647\u20131653 (2014)","journal-title":"J. Gen. Virol."},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","volume":"111","author":"CA Hanlon","year":"2005","unstructured":"Hanlon, C.A., et al.: Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 111, 44\u201354 (2005)","journal-title":"Virus Res."},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","volume":"23","author":"SM Brookes","year":"2005","unstructured":"Brookes, S.M., Parsons, G., Johnson, N., McElhinney, L.M., Fooks, A.R.: Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine. 23, 4101\u20134109 (2005)","journal-title":"Vaccine"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1099\/vir.0.061952-0","volume":"95","author":"DL Horton","year":"2014","unstructured":"Horton, D.L., et al.: Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus. J. Gen. Virol. 95, 1025\u20131032 (2014)","journal-title":"J. Gen. Virol."},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","volume":"75","author":"H Badrane","year":"2001","unstructured":"Badrane, H., Bahloul, C., Perrin, P., Tordo, N.: Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 75, 3268\u20133276 (2001)","journal-title":"J. Virol."},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"16328","DOI":"10.1073\/pnas.0407289101","volume":"101","author":"M Faber","year":"2004","unstructured":"Faber, M., et al.: Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. U. S. A. 101, 16328\u201316332 (2004)","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1128\/JVI.01665-09","volume":"84","author":"S Finke","year":"2010","unstructured":"Finke, S., Granzow, H., Hurst, J., Pollin, R., Mettenleiter, T.C.: Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation. J. Virol. 84, 1816\u20131827 (2010)","journal-title":"J. Virol."},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1128\/JVI.02327-07","volume":"82","author":"R Pulmanausahakul","year":"2008","unstructured":"Pulmanausahakul, R., Li, J., Schnell, M.J., Dietzschold, B.: The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. J. Virol. 82, 2330\u20132338 (2008)","journal-title":"J. Virol."},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virusres.2012.01.002","volume":"165","author":"K Yamada","year":"2012","unstructured":"Yamada, K., et al.: Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus. Virus Res. 165, 34\u201345 (2012)","journal-title":"Virus Res."},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7883\/yoken.JJID.2014.533","volume":"68","author":"N Hamamoto","year":"2015","unstructured":"Hamamoto, N., et al.: Association between RABV G proteins transported from the perinuclear space to the cell surface membrane and N-glycosylation of the Sequon Asn(204). Jpn. J. Infect. Dis. 68, 387\u2013393 (2015)","journal-title":"Jpn. J. Infect. Dis."},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1099\/vir.0.047852-0","volume":"94","author":"K Yamada","year":"2013","unstructured":"Yamada, K., et al.: Addition of a single N-glycan to street rabies virus glycoprotein enhances virus production. J. Gen. Virol. 94, 270\u2013275 (2013)","journal-title":"J. Gen. Virol."},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00705-013-1805-5","volume":"159","author":"K Yamada","year":"2014","unstructured":"Yamada, K., Noguchi, K., Nishizono, A.: Characterization of street rabies virus variants with an additional N-glycan at position 247 in the glycoprotein. Arch. Virol. 159, 207\u2013216 (2014)","journal-title":"Arch. Virol."},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1126\/science.7053569","volume":"215","author":"TL Lentz","year":"1982","unstructured":"Lentz, T.L., Burrage, T.G., Smith, A.L., Crick, J., Tignor, G.H.: Is the acetylcholine receptor a rabies virus receptor? Science. 215, 182\u2013184 (1982)","journal-title":"Science"},{"issue":"Pt 10","key":"10_CR18","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1099\/0022-1317-77-10-2437","volume":"77","author":"M Gastka","year":"1996","unstructured":"Gastka, M., Horvath, J., Lentz, T.L.: Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay. J. Gen. Virol. 77(Pt 10), 2437\u20132440 (1996)","journal-title":"J. Gen. Virol."},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","volume":"17","author":"C Tuffereau","year":"1998","unstructured":"Tuffereau, C., Benejean, J., Blondel, D., Kieffer, B., Flamand, A.: Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17, 7250\u20137259 (1998)","journal-title":"EMBO J."},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","volume":"72","author":"MI Thoulouze","year":"1998","unstructured":"Thoulouze, M.I., et al.: The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72, 7181\u20137190 (1998)","journal-title":"J. Virol."},{"key":"10_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007189","volume":"14","author":"J Wang","year":"2018","unstructured":"Wang, J., et al.: Metabotropic glutamate receptor subtype 2 is a cellular receptor for rabies virus. PLoS Pathog. 14, e1007189 (2018)","journal-title":"PLoS Pathog."},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1083\/jcb.150.3.601","volume":"150","author":"Y Gaudin","year":"2000","unstructured":"Gaudin, Y.: Rabies virus-induced membrane fusion pathway. J. Cell Biol. 150, 601\u2013612 (2000)","journal-title":"J. Cell Biol."},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"17575","DOI":"10.1074\/jbc.270.29.17575","volume":"270","author":"P Durrer","year":"1995","unstructured":"Durrer, P., Gaudin, Y., Ruigrok, R.W., Graf, R., Brunner, J.: Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses. J. Biol. Chem. 270, 17575\u201317581 (1995)","journal-title":"J. Biol. Chem."},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","volume":"65","author":"A Benmansour","year":"1991","unstructured":"Benmansour, A., et al.: Antigenicity of rabies virus glycoprotein. J. Virol. 65, 4198\u20134203 (1991)","journal-title":"J. Virol."},{"issue":"Pt 2","key":"10_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","volume":"70","author":"H Bunschoten","year":"1989","unstructured":"Bunschoten, H., et al.: Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J. Gen. Virol. 70(Pt 2), 291\u2013298 (1989)","journal-title":"J. Gen. Virol."},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1073\/pnas.80.1.70","volume":"80","author":"B Dietzschold","year":"1983","unstructured":"Dietzschold, B., et al.: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. U. S. A. 80, 70\u201374 (1983)","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"037","DOI":"10.4172\/jaa.1000061","volume":"5","author":"NA Kuzmina","year":"2013","unstructured":"Kuzmina, N.A., Kuzmin, I.V., Ellison, J.A., Rupprecht, C.E.: Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein. J. Antivir. Antiretrovir. 5, 037\u2013043 (2013)","journal-title":"J. Antivir. Antiretrovir."},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0168-1702(97)00080-4","volume":"51","author":"TR Luo","year":"1997","unstructured":"Luo, T.R., et al.: A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Res. 51, 35\u201341 (1997)","journal-title":"Virus Res."},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","volume":"53","author":"I Seif","year":"1985","unstructured":"Seif, I., Coulon, P., Rollin, P.E., Flamand, A.: Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53, 926\u2013934 (1985)","journal-title":"J. Virol."},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1348-0421.2010.00262.x","volume":"54","author":"T Matsumoto","year":"2010","unstructured":"Matsumoto, T., et al.: Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus. Microbiol. Immunol. 54, 673\u2013683 (2010)","journal-title":"Microbiol. Immunol."},{"issue":"Pt 4","key":"10_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","volume":"64","author":"M Lafon","year":"1983","unstructured":"Lafon, M., Wiktor, T.J., Macfarlan, R.I.: Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J. Gen. Virol. 64(Pt 4), 843\u2013851 (1983)","journal-title":"J. Gen. Virol."},{"key":"10_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000542","volume":"3","author":"T Muller","year":"2009","unstructured":"Muller, T., et al.: Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl. Trop. Dis. 3, e542 (2009)","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cell.2018.02.025","volume":"172","author":"GF Gao","year":"2018","unstructured":"Gao, G.F.: From \u201ca\u201dIV to \u201cZ\u201dIKV: attacks from emerging and re-emerging pathogens. Cell. 172, 1157\u20131159 (2018)","journal-title":"Cell"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.20506\/rst.26.1.1730","volume":"26","author":"JA Mumford","year":"2007","unstructured":"Mumford, J.A.: Vaccines and viral antigenic diversity. Rev. Sci. Tech. 26, 69\u201390 (2007)","journal-title":"Rev. Sci. Tech."},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D.J., et al.: Mapping the antigenic and genetic evolution of influenza virus. Science. 305, 371\u2013376 (2004)","journal-title":"Science"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/molbev\/msh109","volume":"21","author":"K Hanada","year":"2004","unstructured":"Hanada, K., Suzuki, Y., Gojobori, T.: A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol. Biol. Evol. 21, 1074\u20131080 (2004)","journal-title":"Mol. Biol. Evol."},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1099\/vir.0.2008\/003913-0","volume":"89","author":"H Bourhy","year":"2008","unstructured":"Bourhy, H., et al.: The origin and phylogeography of dog rabies virus. J. Gen. Virol. 89, 2673\u20132681 (2008)","journal-title":"J. Gen. Virol."},{"key":"10_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006041","volume":"12","author":"C Troupin","year":"2016","unstructured":"Troupin, C., et al.: Large-scale phylogenomic analysis reveals the complex evolutionary history of rabies virus in multiple carnivore hosts. PLoS Pathog. 12, e1006041 (2016)","journal-title":"PLoS Pathog."},{"key":"10_CR39","first-page":"101","volume":"21","author":"M Ajorloo","year":"2018","unstructured":"Ajorloo, M., et al.: Evaluation and phylogenetic analysis of regular rabies virus vaccine strains. Arch. Iran. Med. 21, 101\u2013110 (2018)","journal-title":"Arch. Iran. Med."},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s13337-015-0285-5","volume":"26","author":"AC Patel","year":"2015","unstructured":"Patel, A.C., et al.: Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabies virus and future prospect in vaccination strategy. Virus. 26, 288\u2013296 (2015)","journal-title":"Virus"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00705-014-2045-z","volume":"159","author":"A Orlowska","year":"2014","unstructured":"Orlowska, A., Zmudzinski, J.F.: Molecular epidemiology of rabies virus in Poland. Arch. Virol. 159, 2043\u20132050 (2014)","journal-title":"Arch. Virol."},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF02240413","volume":"22","author":"HO Aghomo","year":"1990","unstructured":"Aghomo, H.O., Rupprecht, C.E.: Antigenic characterisation of virus isolates from vaccinated dogs dying of rabies. Trop. Anim. Health Prod. 22, 275\u2013280 (1990)","journal-title":"Trop. Anim. Health Prod."},{"key":"10_CR43","first-page":"222","volume":"37","author":"JU Umoh","year":"1990","unstructured":"Umoh, J.U., Cox, J.H., Schneider, L.G.: Antigenic characterization of street rabies virus isolates from Nigeria using monoclonal antibodies. Zentralbl. Veterinarmed. B. 37, 222\u2013228 (1990)","journal-title":"Zentralbl. Veterinarmed. B."},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1023\/A:1006412516340","volume":"24","author":"AE Okoh","year":"2000","unstructured":"Okoh, A.E.: Antigenic characterization of rabies virus isolates from vaccinated dogs in plateau state, Nigeria. Vet. Res. Commun. 24, 203\u2013211 (2000)","journal-title":"Vet. Res. Commun."},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jviromet.2011.04.019","volume":"175","author":"C Zanluca","year":"2011","unstructured":"Zanluca, C., et al.: Novel monoclonal antibodies that bind to wild and fixed rabies virus strains. J. Virol. Methods. 175, 66\u201373 (2011)","journal-title":"J. Virol. Methods"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.152.1.99","volume":"152","author":"TJ Wiktor","year":"1980","unstructured":"Wiktor, T.J., Koprowski, H.: Antigenic variants of rabies virus. J. Exp. Med. 152, 99\u2013112 (1980)","journal-title":"J. Exp. Med."},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/oxfordjournals.aje.a113583","volume":"117","author":"P Sureau","year":"1983","unstructured":"Sureau, P., Rollin, P., Wiktor, T.J.: Epidemiologic analysis of antigenic variations of street rabies virus: detection by monoclonal antibodies. Am. J. Epidemiol. 117, 605\u2013609 (1983)","journal-title":"Am. J. Epidemiol."},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","volume":"79","author":"AB Bakker","year":"2005","unstructured":"Bakker, A.B., et al.: Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J. Virol. 79, 9062\u20139068 (2005)","journal-title":"J. Virol."},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","volume":"79","author":"WE Marissen","year":"2005","unstructured":"Marissen, W.E., et al.: Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J. Virol. 79, 4672\u20134678 (2005)","journal-title":"J. Virol."},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"42769","DOI":"10.1038\/srep42769","volume":"7","author":"J Nie","year":"2017","unstructured":"Nie, J., et al.: Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system. Sci. Rep. 7, 42769 (2017)","journal-title":"Sci. Rep."},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1080\/22221751.2019.1683436","volume":"8","author":"W Wang","year":"2019","unstructured":"Wang, W., et al.: Antigenic variations of recent street rabies virus. Emerg. Microbes Infect. 8, 1584\u20131592 (2019)","journal-title":"Emerg. Microbes Infect."},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"7178","DOI":"10.1016\/j.vaccine.2009.09.024","volume":"27","author":"E Wright","year":"2009","unstructured":"Wright, E., et al.: A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine. 27, 7178\u20137186 (2009)","journal-title":"Vaccine"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","volume":"89","author":"E Wright","year":"2008","unstructured":"Wright, E., et al.: Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J. Gen. Virol. 89, 2204\u20132213 (2008)","journal-title":"J. Gen. Virol."},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.virol.2010.09.014","volume":"408","author":"E Wright","year":"2010","unstructured":"Wright, E., et al.: Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses. Virology. 408, 183\u2013189 (2010)","journal-title":"Virology"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"407","DOI":"10.15252\/emmm.201505986","volume":"8","author":"P De Benedictis","year":"2016","unstructured":"De Benedictis, P., et al.: Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol. Med. 8, 407\u2013421 (2016)","journal-title":"EMBO Mol. Med."},{"key":"10_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071383","volume":"8","author":"BM Boruah","year":"2013","unstructured":"Boruah, B.M., et al.: Single domain antibody multimers confer protection against rabies infection. PLoS One. 8, e71383 (2013)","journal-title":"PLoS One"},{"key":"10_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.598241","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu, J., et al.: Clofazimine: a promising inhibitor of rabies virus. Front. Pharmacol. 12, 598241 (2021)","journal-title":"Front. Pharmacol."},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-0556-7-1","volume":"7","author":"T Federici","year":"2009","unstructured":"Federici, T., et al.: Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer. Genet. Vaccines Ther. 7, 1 (2009)","journal-title":"Genet. Vaccines Ther."},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1006\/mthe.2002.0584","volume":"5","author":"DJ Watson","year":"2002","unstructured":"Watson, D.J., Kobinger, G.P., Passini, M.A., Wilson, J.M., Wolfe, J.H.: Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol. Ther. 5, 528\u2013537 (2002)","journal-title":"Mol. Ther."},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/tbed.13826","volume":"68","author":"DK Meza","year":"2021","unstructured":"Meza, D.K., et al.: Predicting the presence and titre of rabies virus-neutralizing antibodies from low-volume serum samples in low-containment facilities. Transbound. Emerg. Dis. 68, 1564\u20131576 (2021)","journal-title":"Transbound. Emerg. Dis."},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1080\/22221751.2022.2078742","volume":"11","author":"M Cai","year":"2022","unstructured":"Cai, M., et al.: Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains. Emerg. Microbes Infect. 11, 1474\u20131487 (2022)","journal-title":"Emerg. Microbes Infect."},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v8090254","volume":"8","author":"S Moeschler","year":"2016","unstructured":"Moeschler, S., Locher, S., Conzelmann, K.K., Kramer, B., Zimmer, G.: Quantification of lyssavirus-neutralizing antibodies using vesicular stomatitis virus Pseudotype particles. Viruses. 8, 254 (2016)","journal-title":"Viruses"},{"key":"10_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virol.2013.06.016","volume":"444","author":"DL Weir","year":"2013","unstructured":"Weir, D.L., Smith, I.L., Bossart, K.N., Wang, L.F., Broder, C.C.: Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins. Virology. 444, 21\u201330 (2013)","journal-title":"Virology"},{"key":"10_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1963","volume":"28","author":"Q Li","year":"2018","unstructured":"Li, Q., Liu, Q., Huang, W., Li, X., Wang, Y.: Current status on the development of pseudoviruses for enveloped viruses. Rev. Med. Virol. 28, e1963 (2018)","journal-title":"Rev. Med. Virol."},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/v8040107","volume":"8","author":"J Nie","year":"2016","unstructured":"Nie, J., Liu, Y., Huang, W., Wang, Y.: Development of a triple-color Pseudovirion-based assay to detect neutralizing antibodies against human papillomavirus. Viruses. 8, 107 (2016)","journal-title":"Viruses"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1089\/hum.2010.063","volume":"21","author":"T Sakuma","year":"2010","unstructured":"Sakuma, T., et al.: Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Hum. Gene Ther. 21, 1665\u20131673 (2010)","journal-title":"Hum. Gene Ther."},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1016\/j.vaccine.2017.07.101","volume":"35","author":"Q Li","year":"2017","unstructured":"Li, Q., et al.: An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine. 35, 5172\u20135178 (2017)","journal-title":"Vaccine"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/22221751.2019.1571871","volume":"8","author":"J Nie","year":"2019","unstructured":"Nie, J., et al.: Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg. Microbes Infect. 8, 272\u2013281 (2019)","journal-title":"Emerg. Microbes Infect."},{"key":"10_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/infdis\/jiy408","volume":"219","author":"T Ning","year":"2019","unstructured":"Ning, T., et al.: Antigenic drift of influenza a(H7N9) virus hemagglutinin. J. Infect. Dis. 219, 19\u201325 (2019)","journal-title":"J. Infect. Dis."},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1016\/j.vaccine.2017.10.007","volume":"35","author":"J Wu","year":"2017","unstructured":"Wu, J., Zhao, C., Liu, Q., Huang, W., Wang, Y.: Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system. Vaccine. 35, 6387\u20136394 (2017)","journal-title":"Vaccine"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/gt.2011.124","volume":"19","author":"DC Carpentier","year":"2012","unstructured":"Carpentier, D.C., et al.: Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies\/vesicular stomatitis virus chimeric envelope glycoprotein. Gene Ther. 19, 761\u2013774 (2012)","journal-title":"Gene Ther."},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/vim.2021.0181","volume":"35","author":"WM Khalil","year":"2022","unstructured":"Khalil, W.M., Aboshanab, K.M., Aboulwafa, M.M.: Evaluation and correlation of rabies vaccine potency using the National Institute of health, rapid focus fluorescent inhibition, and passive hemagglutination tests. Viral Immunol. 35, 159\u2013169 (2022)","journal-title":"Viral Immunol."},{"key":"10_CR73","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1016\/j.vaccine.2012.06.089","volume":"30","author":"P De Benedictis","year":"2012","unstructured":"De Benedictis, P., Mancin, M., Cattoli, G., Capua, I., Terrregino, C.: Serological methods used for rabies post vaccination surveys: an analysis. Vaccine. 30, 5611\u20135615 (2012)","journal-title":"Vaccine"},{"key":"10_CR74","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12250-012-3260-y","volume":"27","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Zhang, S., Zhang, F., Hu, R.: A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use. Virol. Sin. 27, 259\u2013264 (2012)","journal-title":"Virol. Sin."},{"key":"10_CR75","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.vaccine.2015.04.071","volume":"33","author":"EM Bentley","year":"2015","unstructured":"Bentley, E.M., Mather, S.T., Temperton, N.J.: The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination. Vaccine. 33, 2955\u20132962 (2015)","journal-title":"Vaccine"},{"key":"10_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1099\/jgv.0.000998","volume":"99","author":"JS Evans","year":"2018","unstructured":"Evans, J.S., et al.: Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses. J. Gen. Virol. 99, 169\u2013180 (2018)","journal-title":"J. Gen. Virol."},{"key":"10_CR77","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1016\/j.vaccine.2012.09.027","volume":"30","author":"N Gogtay","year":"2012","unstructured":"Gogtay, N., et al.: Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults. Vaccine. 30, 7315\u20137320 (2012)","journal-title":"Vaccine"},{"key":"10_CR78","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","volume":"25","author":"SE Sloan","year":"2007","unstructured":"Sloan, S.E., et al.: Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine. 25, 2800\u20132810 (2007)","journal-title":"Vaccine"},{"key":"10_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006133","volume":"11","author":"TY Chao","year":"2017","unstructured":"Chao, T.Y., et al.: SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl. Trop. Dis. 11, e0006133 (2017)","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10_CR80","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/tropicalmed2030048","volume":"2","author":"R Franka","year":"2017","unstructured":"Franka, R., et al.: In vivo efficacy of a cocktail of human monoclonal antibodies (CL184) against diverse North American bat rabies virus variants. Trop. Med. Infect. Dis. 2, 48 (2017)","journal-title":"Trop. Med. Infect. Dis."},{"key":"10_CR81","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012628","volume":"12","author":"GD de Melo","year":"2020","unstructured":"de Melo, G.D., et al.: A combination of two human monoclonal antibodies cures symptomatic rabies. EMBO Mol. Med. 12, e12628 (2020)","journal-title":"EMBO Mol. Med."},{"key":"10_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1128\/jvi.56.1.12-18.1985","volume":"56","author":"B Dietzschold","year":"1985","unstructured":"Dietzschold, B., et al.: Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J. Virol. 56, 12\u201318 (1985)","journal-title":"J. Virol."},{"key":"10_CR83","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nm0898-949","volume":"4","author":"DL Lodmell","year":"1998","unstructured":"Lodmell, D.L., et al.: DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 4, 949\u2013952 (1998)","journal-title":"Nat. Med."},{"key":"10_CR84","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0042-6822(89)90551-5","volume":"173","author":"C Prehaud","year":"1989","unstructured":"Prehaud, C., Takehara, K., Flamand, A., Bishop, D.H.: Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology. 173, 390\u2013399 (1989)","journal-title":"Virology"},{"key":"10_CR85","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/JVI.73.1.510-518.1999","volume":"73","author":"K Morimoto","year":"1999","unstructured":"Morimoto, K., Hooper, D.C., Spitsin, S., Koprowski, H., Dietzschold, B.: Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73, 510\u2013518 (1999)","journal-title":"J. Virol."},{"key":"10_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053273","volume":"8","author":"CJ Bonhomme","year":"2013","unstructured":"Bonhomme, C.J., Knopp, K.A., Bederka, L.H., Angelini, M.M., Buchmeier, M.J.: LCMV glycosylation modulates viral fitness and cell tropism. PLoS One. 8, e53273 (2013)","journal-title":"PLoS One"},{"key":"10_CR87","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/14760584.2021.1908135","volume":"20","author":"P Ge","year":"2021","unstructured":"Ge, P., Ross, T.M.: Evolution of a(H1N1) pdm09 influenza virus masking by glycosylation. Expert Rev. Vaccines. 20, 519\u2013526 (2021)","journal-title":"Expert Rev. Vaccines"},{"key":"10_CR88","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v10040183","volume":"10","author":"P Kim","year":"2018","unstructured":"Kim, P., et al.: Glycosylation of hemagglutinin and neuraminidase of influenza a virus as signature for ecological Spillover and adaptation among influenza reservoirs. Viruses. 10, 183 (2018)","journal-title":"Viruses"},{"key":"10_CR89","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1128\/JVI.02785-13","volume":"88","author":"PJ Yen","year":"2014","unstructured":"Yen, P.J., et al.: Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission. J. Virol. 88, 5014\u20135028 (2014)","journal-title":"J. Virol."},{"key":"10_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-4690-10-14","volume":"10","author":"W Wang","year":"2013","unstructured":"Wang, W., et al.: A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. Retrovirology. 10, 14 (2013)","journal-title":"Retrovirology"},{"key":"10_CR91","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/QAI.0000000000000595","volume":"69","author":"W Wang","year":"2015","unstructured":"Wang, W., et al.: N463 glycosylation site on V5 loop of a mutant gp120 regulates the sensitivity of HIV-1 to neutralizing monoclonal antibodies VRC01\/03. J. Acquir. Immune Defic. Syndr. 69, 270\u2013277 (2015)","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10_CR92","doi-asserted-by":"crossref","unstructured":"Du Pont, V., et al.: Identification and characterization of a small-molecule rabies virus entry inhibitor. J. Virol. 94 (2020)","DOI":"10.1128\/JVI.00321-20"},{"key":"10_CR93","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1128\/JVI.00636-15","volume":"89","author":"MB Mues","year":"2015","unstructured":"Mues, M.B., Cheshenko, N., Wilson, D.W., Gunther-Cummins, L., Herold, B.C.: Dynasore disrupts trafficking of herpes simplex virus proteins. J. Virol. 89, 6673\u20136684 (2015)","journal-title":"J. Virol."},{"key":"10_CR94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1743-422X-11-40","volume":"11","author":"DL Weir","year":"2014","unstructured":"Weir, D.L., Laing, E.D., Smith, I.L., Wang, L.F., Broder, C.C.: Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5. Virol. J. 11, 40 (2014)","journal-title":"Virol. J."}],"container-title":["Advances in Experimental Medicine and Biology","Pseudotyped Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-0113-5_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:25:25Z","timestamp":1678879525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-0113-5_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819901128","9789819901135"],"references-count":94,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-0113-5_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"16 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}